Ace Report Cover
OTA 2019: No significant difference with bupivacaine injection at surgical site in hip fractures
Reprints
Cite This
Reprints
Cite This
AceReport Image
Trauma
OTA 2019: No significant difference with bupivacaine injection at surgical site in hip fractures

Hip fractures are very common, and pain management is an issue. Pain itself can cause this pre-disposed population to experience confusion and delirium. On the other hand, opioid medications often used to treat the pain can often have the same effects. Thus, efficacious non-opioid pain management strategies are of great interest in hip fracture patients. The investigators randomized 55 patients to receive an injection of bupivacaine or saline at the fracture site. Opioid use, pain and Confusion Assessment Method (CAM) Scores were collected at 24, 48, and 72 hours. Overall, there were no significant differences in any outcome at any time point. Though this was a small trial, there was no effect demonstrated for bupivacaine.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. OTA 2019: No significant difference with bupivacaine injection at surgical site in hip fractures. ACE Report. 2019;9(10):20. Available from: https://myorthoevidence.com/AceReport/Report/ota-2019-no-significant-difference-with-bupivacaine-injection-at-surgical-site-in-hip-fractures

Copy Citation
Share this Ace Report